RxDoctor Payments Data

Eric Downes, MD

Psychiatry · Ocoee, FLNPI 1710368840

Payments from drug & device makers

$996in general payments, 2019–2025

Across 58 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$444
  • Tris Pharma Inc$133
  • Takeda Pharmaceuticals U.S.A., Inc.$132
  • Johnson & Johnson$67
  • Sunovion Pharmaceuticals Inc.$64
  • Otsuka America Pharmaceutical, Inc.$36
  • plus $120 from 7 others

What the payments were for

  • Food & beverage$98198%
  • Education$162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$996 in reported general payments places this provider in the 60th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$18,692
Medicare patients
30
Services billed
168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$103,711
Austedo XrDeutetrabenazine13$102,710
TrintellixVortioxetine Hydrobromide12$8,063
Adzenys Xr-OdtAmphetamine13$6,206
Paliperidone ErPaliperidone18$2,946
Duloxetine Hcl101$1,933
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine37$1,444
Quetiapine Fumarate67$1,364
Trazodone Hcl130$1,258
Bupropion XlBupropion Hcl53$1,198
Lamotrigine88$970
Clonazepam90$887
Gabapentin35$758
Desvenlafaxine Succinate ErDesvenlafaxine Succinate15$710
Aripiprazole26$701

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$132$8,06312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Ocoee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →